beta
Text
Defendants shall be punished by a fine of KRW 3,000,000.
Defendant
If A does not pay the above fine, 100.
Reasons
Punishment of the crime
1. The defendant A is a joint representative director of Gangseo-gu Seoul Metropolitan Government and B in accordance with subparagraph 3 or 201, who exercises overall control over the above company's affairs.
A person who may sell drugs, etc. shall observe matters necessary for the establishment of a distribution system of drugs, etc. and maintenance of order in sales, and shall not sell drugs to a person other than those who are entitled to sell drugs.
Nevertheless, around March 26, 2014, the Defendant purchased approximately 250 ml 100 ml. Megarac 100 ml. 6,500 won per dog to D, who is not qualified for the sale of medicines, and sold them to KRW 8,000. From November 1, 2012 to August 28, 2014, the Defendant received and sold the drugs of category 6 m. 14,582,00 won in total on eight occasions as shown in the list of crimes in attached Table.
2. Defendant B is a corporation established for the purpose of wholesale and retailing drugs, Korean pest control agents, health auxiliary foods, etc.
A, a joint representative director of the defendant, performed the act of selling medicines to a person who is not entitled to sell medicines as above at the date and place specified in Paragraph (1) of the decision.
Summary of Evidence
1. Defendant A’s legal statement
1. A copy of the protocol of interrogation of the police officer regarding D (second time);
1. Investigation report (report on detection of a person in violation of the Pharmaceutical Affairs Act), details of purchase and sale by B ridok, copies of the license for the sale of medicines B, Class 6 summary information, such as telac, telac, etc., list of sale of medicines, list of sales by medicines, and application of statutes governing the sale of medicines;
1. Article 95(1)8 of the former Pharmaceutical Affairs Act (amended by Act No. 13219, Mar. 13, 2015); Article 95(1)8 of the same Act (amended by Act No. 13219, Mar. 13, 2015); Article 47(1) of the same Act (amended by Act No. 13219, Mar. 13, 2015); Defendant B: Articles 97, 95(1)8, and 47(1) of the same Act (amended by Act No. 13219, Mar. 13, 2015).